Ocaro Pharmaceuticals
Greensboro, US · Delaware corporation
Find your way into Ocaro Pharmaceuticals
Sign up to see every warm intro you have to Ocaro Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ocaro Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RJ
Roland JohnsonNamed on SEC filing
LS
Lanty SmithNamed on SEC filing
BY
Bill YatesNamed on SEC filing
EB
Eric BarnettNamed on SEC filing
AJ
Andy JaneNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$610K disclosed across 1 round · 2022
▶$610KraisedNov 2022 · 12 investors · PharmaceuticalsRule 506(b)
▶$610KraisedNov 2022 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Roland JohnsonExecutive Officer, Director
- Lanty SmithDirector
- Bill YatesDirector
- Eric BarnettExecutive Officer
- Andy JaneDirector
- Offering amount
- $610K
- Amount sold
- $610K
- Minimum investment
- $30K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ocaro Pharmaceuticals raised?
- Ocaro Pharmaceuticals has disclosed $610K raised across 1 round.
- Where is Ocaro Pharmaceuticals headquartered?
- Ocaro Pharmaceuticals is headquartered in Greensboro, US.